1. Home
  2. AZTA vs BHVN Comparison

AZTA vs BHVN Comparison

Compare AZTA & BHVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Azenta Inc.

AZTA

Azenta Inc.

HOLD

Current Price

$22.32

Market Cap

1.4B

Sector

Technology

ML Signal

HOLD

Logo Biohaven Ltd.

BHVN

Biohaven Ltd.

HOLD

Current Price

$9.28

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AZTA
BHVN
Founded
1978
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.6B
IPO Year
1996
2022

Fundamental Metrics

Financial Performance
Metric
AZTA
BHVN
Price
$22.32
$9.28
Analyst Decision
Strong Buy
Buy
Analyst Count
5
14
Target Price
$42.60
$28.85
AVG Volume (30 Days)
778.9K
1.8M
Earning Date
05-04-2026
06-08-2026
Dividend Yield
N/A
N/A
EPS Growth
60.52
26.08
EPS
N/A
N/A
Revenue
$593,821,000.00
N/A
Revenue This Year
$6.25
N/A
Revenue Next Year
$5.42
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.45
$7.48
52 Week High
$41.73
$31.18

Technical Indicators

Market Signals
Indicator
AZTA
BHVN
Relative Strength Index (RSI) 28.97 32.81
Support Level N/A $8.40
Resistance Level $31.87 $10.28
Average True Range (ATR) 1.07 0.71
MACD 0.01 -0.12
Stochastic Oscillator 25.21 2.20

Price Performance

Historical Comparison
AZTA
BHVN

About AZTA Azenta Inc.

Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.

About BHVN Biohaven Ltd.

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of life-changing treatments in key therapeutic areas, including immunology, neuroscience, and oncology. Its product pipeline includes Glutamate, Myostatin, Ion channels, Inflammation & Immunology, and Oncology. The company's products target diseases such as neuromuscular and metabolic diseases, antibody-drug conjugates for cancer, obsessive-compulsive disorder, and others.

Share on Social Networks: